Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
10.80
+0.50 (4.85%)
Apr 1, 2026, 1:09 PM CET
Market Cap2.32B +4,976.5%
Revenue (ttm)n/a
Net Income-6.60M
EPS-0.11
Shares Out214.91M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,267,363
Average Volume17,820,572
Open10.18
Previous Close10.30
Day's Range9.82 - 11.10
52-Week Range0.50 - 11.10
Beta-1.21
RSI90.17
Earnings DateApr 15, 2026

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements